Although SHP-1 has been demonstrated to be an inhibitor of cell proliferation, knockdown of SHP-1 was recently reported to downregulate CDK6 and inhibit G1/S progression in prostate cancer cells (20). Here, CDK6 is linked to prostate carcinoma.